Christopher-Paul Milne, Tufts Center for the Study of Drug Development

Christopher-Paul Milne, D.V.M., M.P.H., J.D., Associate Director, joined the Tufts Center for the Study of Drug Development (Tufts CSDD) in 1998 as a Senior Research Fellow in order to address legal and regulatory issues. His current research interests include: challenges to the R&D of new drugs; innovation capacity in the developing world; incentive programs for pediatric studies, orphan products, and neglected diseases; assessing the impact of regulatory policy; and, tracking progress of new safety and science initiatives. He is currently a member of the Editorial Board of the Food & Drug Law Journal and the Executive Program Committee for the Drug Information Association 2010 Annual Meeting, as well as an Honorary Fellow at the University of Edinburgh.

Read Christopher Milne’s latest contributions to The Age of Personalized Medicine Blog